Global Pharmaceutical Grade Sodium Carbonate Sales Continue to Decline, Consumption by API Applications Persists

Pharmaceutical Grade Sodium Carbonate Market

Future Market Insights recently published a research report on the global pharmaceutical grade sodium carbonate, titled “Pharmaceutical Grade Sodium Carbonate Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027).” The global sales of pharmaceutical grade sodium carbonate are expected to be lethargic throughout the next decade. Although manufacturing of drugs meant for treating gastrointestinal diseases demands pharmaceutical grade sodium carbonate, expensive pricing will remain a major barrier to its significant adoption. There are a few other factors too, which lead to passive growth of global pharmaceutical grade sodium carbonate market.

While the report provides an extensive assessment of the market and detailed information about the key factors influencing its growth, recent trends, opportunities, and key company developments, our research analyst offers precise answers to key queries.

According to you, where would the market for pharmaceutical grade sodium carbonate reach in terms of value, by 2027?

In terms of value, the global sales of pharmaceutical grade sodium carbonate will possibly reach a value of US$ 50 Mn by 2027 end. It was valuated at US$ 38 Mn in 2017, which represents poor growth over the forecast period at a CAGR of 2.8%

Is manufacturing of drugs for gastrointestinal diseases not sufficient to sustain the demand for sodium carbonate at a decent rate over the next decade?

No. There is an evident increase in consumption of drugs and antacids prescribed against various gastrointestinal disorders, which seemingly push the demand for sodium carbonate. However, the impact of restraining factors is observed to be much more intense, which is why the market is slated for poor growth over the next decade.

What are the key challenges limiting the growth of market?

Handling of pharmaceutical grade sodium carbonate during a series of manufacturing processes requires high caution and it ultimately offers much lesser volume of the final product. Production costs incurred in such processes are often high, eventually resulting in expensive prices of pharmaceutical grade sodium carbonate. While expensive pricing will remain the key challenge, bulk consumption of pharmaceutical grade sodium carbonate in niche, specialty, and high-cost applications also represents an important factor that restricts its adoption and sales.

Which end-use application consumes the largest amount of pharmaceutical grade sodium carbonate?

In terms of end-use application, pharmaceutical grade sodium carbonate registers the highest consumption by API segment. Various pharma companies use sodium carbonate as an excipient during manufacturing of active pharmaceutical ingredients (API) in order to enhance drugs.

What are the key players operating the global market for pharmaceutical grade sodium carbonate?

Our report throws light on the key companies, their activities, strategies, and current and estimated market scenario. Some of the key players are Solvay SA, Novacarb (Novacap Group), Dr. Paul Lohmann GmbH KG, CIECH S.A., Natural Soda LLC, Jost Chemical Co., Tianjin Chengyuan Chemical Co. Ltd., Weifang Hongyuan Chemical Co. Ltd., and Tronox Alkali Corporation.

Currently, Asia Pacific (excluding Japan) is the fastest growing regional market for pharmaceutical grade sodium carbonate. In terms of market size, APEJ follows the two key regions i.e. North America and Western Europe. Will APEJ outpace the two leading regional markets in upcoming decade owing to increasing application-based opportunities? Know more from our analysts at Future Market

Request Report Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-6420

About Nikhil Kaitwade 290 Articles
With over 8 years of experience in market research and consulting industry, Nikhil has worked on more than 250 research assignments pertaining to chemicals, materials and energy sector. He has worked directly with about 35 reputed companies as lead consultant for plant expansion, product positioning, capacity factor analysis, new market/segment exploration, export market opportunity evaluation and sourcing strategies.